Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
INDUSTRY
×
Hereditary Sensory and Autonomic Neuropathies
×
Clear all
Filters
3
NCT03439046
2024-08-01
BioItaLEE
Novartis
Phase 3
Completed
287 enrolled
NCT02204982
2023-09-28
DYNAMO + R
SecuraBio
Phase 3
Terminated
13 enrolled
10 charts
1 FDA
NCT01633060
2019-01-30
BELLE-3
Novartis
Phase 3
Terminated
432 enrolled
20 charts